Biologics LAIs

Extending the Reach: The Next Generation of Long-Acting Injectable Depots for Biologics

David Alvaro, Ph.D.

Pharma's Almanac

Biomanufacturing

What are the most significant manufacturing hurdles in biopharma and how can they be addressed?

Pharma's Almanac

Next-Gen Biologics

What do you see as the next big modality in biologics, and what factors are driving innovation in this space?

Pharma's Almanac

Biosimilars

Biosimilars Through the Years: Transforming Access and Cost in Biologics

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Personalized

Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare

Ola Tuvesson; Isa Lindgren, Ph.D.

NorthX Biologics

AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics